
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Mozuku (Cladosiphon okamuranus) is a brown seaweed rich in fucoidan, a sulfated polysaccharide that enhances immune function and reduces inflammation. Its bioactive compounds support joint health by promoting cartilage repair and providing antioxidant protection against cellular damage.

Reported Benefits (Provisional)
Origin & History

Mozuku is a type of brown seaweed native to Okinawa, Japan. It is harvested from the ocean and is known for its slimy texture and unique flavor.
Research Narrative (Provisional)
Research on Mozuku has focused on its potential health benefits, including its high fucoidan content. Some studies suggest it may support immune health, but further research is needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
{"macronutrients": {"protein": "0.3g per 100g", "fiber": "0.5g per 100g"}, "micronutrients": {"iodine": "1.5mg per 100g", "calcium": "15mg per 100g", "magnesium": "30mg per 100g", "iron": "0.5mg per 100g"}, "bioactive_compounds": {"fucoidan": "5-10% of dry weight", "antioxidants": "various phenolic compounds present"}, "bioavailability_notes": "Fucoidan is water-soluble and its bioavailability can be enhanced through enzymatic processing. Iodine is highly bioavailable, but excessive intake should be monitored due to potential thyroid effects."}
Reported Mechanism (Provisional)
Fucoidan in mozuku activates macrophages and natural killer cells through toll-like receptor pathways, enhancing immune response. It inhibits inflammatory mediators like TNF-alpha and interleukin-6 while promoting collagen synthesis in cartilage tissue. The polysaccharide also scavenges free radicals and upregulates antioxidant enzymes including superoxide dismutase.
Clinical Narrative (Provisional)
Limited clinical studies on mozuku specifically exist, though fucoidan research shows promise. A 12-week study with 20 participants found fucoidan supplementation reduced joint pain scores by 30%. Most evidence comes from in vitro and animal studies demonstrating immune-enhancing properties. Human trials are needed to establish optimal dosages and confirm therapeutic benefits for mozuku consumption.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







